Last reviewed · How we verify

NCT03031080: BOND

BOND Study: the Benefit Of Night Splinting in Dupuytrens'

Withdrawn NA Last updated 27 September 2021
What this trial tests

NA trial testing Thermoplastic Hand Splint in Dupuytren Contracture. Withdrawn.

Timeline
1 June 2017
Primary endpoint
31 December 2018
30 June 2019

Quick facts

Lead sponsorLiverpool University Hospitals NHS Foundation Trust
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposesupportive care
Start date1 June 2017
Primary completion31 December 2018
Estimated completion30 June 2019
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Liverpool University Hospitals NHS Foundation Trust

Who can join

Eligibility, any sex, with Dupuytren Contracture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The BOND study is a prospective, randomised single blinded controlled trial to assess the effect of night splinting in patients who have had collagenase injection and manipulation therapy for Dupuytren's Contracture.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Dupuytren Contracture

Currently open trials in the same condition.

Other Liverpool University Hospitals NHS Foundation Trust trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03031080.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing